a year ago
PACB
AnalystsEve BursteinEve Burstein's Stock Forecasts
AnalystsEve Burstein
Analyst Ranking
Top 37%
#1830 out of 5020 analysts
Average Return
+5.98%
Win Rate
54%7 out of 13
Risk vs Reward
Poor
Good
Eve Burstein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Guardant Health IncGH | +147.90% | $23.07 | $57.19 | 2024-10-29 - 2025-09-17 | Buy |
Natera IncNTRA | +38.43% | $126.73 | $175.43 | 2024-10-29 - 2025-09-17 | Buy |
Natera IncNTRA | +38.37% | $96.75 | $133.87 | 2024-04-04 - 2025-04-04 | Buy |
Thermo Fisher Scientific IncTMO | +22.15% | $503.02 | $614.42 | 2023-09-27 - 2024-09-27 | Buy |
Revvity IncRVTY | +14.34% | $110.25 | $126.06 | 2023-09-27 - 2024-09-27 | Buy |
Eve Burstein Analyst Color
Get additional color on Eve Burstein's coverage of popular stocks
Eve Burstein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Agilent Technologies IncA | 5 | Hold | $125.00 | -1.36% | Maintains | 5 months ago |
Natera IncNTRA | 4 | Buy | $200.00 | +14.01% | Maintains | 8 months ago |
Revvity IncRVTY | 2 | Buy | $145.00 | +69.81% | Maintains | 10 months ago |
Waters CorpWAT | 2 | Hold | $360.00 | +18.55% | Maintains | 10 months ago |
Exact Sciences CorpEXAS | 2 | Buy | $90.00 | +71.82% | Maintains | a year ago |
Guardant Health IncGH | 2 | Buy | $35.00 | -38.80% | Maintains | a year ago |
Thermo Fisher Scientific IncTMO | 2 | Hold | $620.00 | +31.18% | Maintains | a year ago |
Pacific Biosciences Of California IncPACB | 2 | Buy | $2.50 | N/A | Maintains | a year ago |
Avantor IncAVTR | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Illumina IncILMN | 1 | Sell | $111.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.